Panel: Ken Tupper, Ethan Nadelmann, David Nutt & Ben de Loenen: Psychedelics and Policy

Psychedelic policy remains heavily driven by political motives rather than scientific evidence. This panel discussion examines how drug prohibition persists despite research findings indicating that certain substances possess legitimate therapeutic potential and lower harm profiles compared to legal alternatives like alcohol. The speakers analyze the historical context of these policies, arguing that political control over drug discourse has historically marginalized scientific findings to serve state interests. They emphasize that public perception, influenced by complex media and corporate narratives, acts as a barrier to evidence based reform and access to treatment. By highlighting the disconnect between the scientific consensus on substance safety and strictly enforced legal frameworks, the panelists advocate for drug policies centered on public health and human rights, urging scholars to engage more actively in shaping public and political perception.